Form 8-K - Current report:
SEC Accession No. 0000950170-25-017114
Filing Date
2025-02-10
Accepted
2025-02-10 16:30:09
Documents
11
Period of Report
2025-02-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K aplt-20250207.htm   iXBRL 8-K 46875
  Complete submission text file 0000950170-25-017114.txt   161402

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aplt-20250207.xsd EX-101.SCH 26288
13 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20250207_htm.xml XML 4864
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 25606110
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)